Building upon our in vitro findings that tumor-mimetic extracellular matrix stiffness suppresses FAT1 expression in LECs, we next characterized the expression pattern of FAT1 in lymphatic vessels during tumor progression in vivo. The gene discussed is FAT1; the disease is neoplasm.